Skip to content
Riskpilot
← Back to search
Sign in
Get full access
UNGMED AB
AB
Active
Org 5568781396
Alviksvägen 4, 645 61
Stallarholmen
General medical practice activities
· NACE 8621
Est. 2011
2 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
UNGMED AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
3M
4M
6M
4M
2021
4M
2022
5M
2023
4M
2024
4M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
2M
2021
1M
2022
2M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
4 384
3 993
4 554
3 899
4 472
Staff expenses
—
—
—
—
—
EBITDA
2 496
1 131
1 713
1 110
1 435
Depreciation & amort.
−338
−296
−371
−393
−417
EBIT
2 158
835
1 342
717
1 018
Net financials
−2
—
6
23
49
Profit before tax
2 156
836
1 348
740
1 068
Tax
−495
−202
−304
−168
−252
Net profit
1 661
634
1 044
572
816
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
5 907
6 279
7 181
7 444
8 131
Equity
5 649
6 022
6 866
7 246
7 858
Long-term debt
0
0
0
0
0
Short-term debt
259
256
314
198
273
Total debt
259
256
314
198
273
Financial ratios
5-year trend
EBITDA margin
32.1%
This company
15.8%
Market median
+103% vs market
2021
2025
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
2021
2025
Return on equity
10.4%
This company
18.4%
Market median
+43% vs market
2021
2025
Net profit margin
18.2%
This company
8.1%
Market median
+125% vs market
2021
2025
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
2021
2025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
View
PDF
More on UNGMED AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network